Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2024 | 2 |
2025 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis.
Am J Physiol Cell Physiol. 2025 Jan 1;328(1):C199-C211. doi: 10.1152/ajpcell.00528.2024. Epub 2024 Nov 7.
Am J Physiol Cell Physiol. 2025.
PMID: 39510135
Free article.
We aimed to study transcriptional and phenotypic changes in circulating immune cells associated with increased risk of mortality in COVID-19, resolution of pulmonary fibrosis in post-COVID-19-interstitial lung disease (ILD), and persistence of idiopathic pulmonary fibro …
We aimed to study transcriptional and phenotypic changes in circulating immune cells associated with increased risk of mortality in COVID-19 …
Onametostat, a PfPRMT5 inhibitor, exhibits antimalarial activity to Plasmodium falciparum.
Min H, Lucky AB, Madsen JJ, Chim-Ong A, Li X, Cui L, Miao J.
Min H, et al.
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0017624. doi: 10.1128/aac.00176-24. Epub 2024 Aug 28.
Antimicrob Agents Chemother. 2024.
PMID: 39194263
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.